205 related articles for article (PubMed ID: 24074814)
41. Treatment adherence in concurrent chemoradiation in patients with locally advanced non-small cell lung carcinoma: results of daily intravenous prehydration.
Uyterlinde W; Chen C; Nijkamp J; Obbink MG; Sonke JJ; Belderbos J; van den Heuvel M
Radiother Oncol; 2014 Mar; 110(3):488-92. PubMed ID: 24444531
[TBL] [Abstract][Full Text] [Related]
42. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
43. A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
Hsia TC; Tu CY; Chen HJ; Chen SC; Liang JA; Chen CY; Wang YC; Chien CR
Anticancer Res; 2014 Sep; 34(9):5175-80. PubMed ID: 25202111
[TBL] [Abstract][Full Text] [Related]
44. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
45. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
46. Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer.
Niho S; Kubota K; Nihei K; Sekine I; Sumi M; Sekiguchi R; Funai J; Enatsu S; Ohe Y; Tamura T
Clin Lung Cancer; 2013 Jan; 14(1):62-9. PubMed ID: 22633219
[TBL] [Abstract][Full Text] [Related]
47. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.
Swanick CW; Lin SH; Sutton J; Naik NS; Allen PK; Levy LB; Liao Z; Welsh JW; Komaki R; Chang JY; Gomez DR
Clin Lung Cancer; 2015 Mar; 16(2):156-63. PubMed ID: 25467928
[TBL] [Abstract][Full Text] [Related]
48. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
49. Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancer.
Jaksic N; Chajon E; Bellec J; Corre R; Ricordel C; de Latour B; Lena H; Schick U; de Crevoisier R; Castelli J
Radiat Oncol; 2018 Aug; 13(1):147. PubMed ID: 30103774
[TBL] [Abstract][Full Text] [Related]
50. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
[TBL] [Abstract][Full Text] [Related]
51. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Wang J; Xia TY; Wang YJ; Li HQ; Li P; Wang JD; Chang DS; Liu LY; Di YP; Wang X; Wu WZ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e59-65. PubMed ID: 21345607
[TBL] [Abstract][Full Text] [Related]
52. Concurrent high-dose radiotherapy with low-dose chemotherapy in patients with non-small cell lung cancer of the superior sulcus.
Kappers I; Klomp HM; Koolen MG; Uitterhoeve LJ; Kloek JJ; Belderbos JS; Burgers JA; Koning CC
Radiother Oncol; 2011 Nov; 101(2):278-83. PubMed ID: 21723638
[TBL] [Abstract][Full Text] [Related]
53. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
[TBL] [Abstract][Full Text] [Related]
54. Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1345-51. PubMed ID: 19910140
[TBL] [Abstract][Full Text] [Related]
55. Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Ning MS; Tang L; Gomez DR; Xu T; Luo Y; Huo J; Mouhayar E; Liao Z
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):70-79. PubMed ID: 28816165
[TBL] [Abstract][Full Text] [Related]
56. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
57. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
[TBL] [Abstract][Full Text] [Related]
58. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM
Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
Wei X; Liu HH; Tucker SL; Liao Z; Hu C; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):100-7. PubMed ID: 16839700
[TBL] [Abstract][Full Text] [Related]
60. Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.
Nijkamp J; Rossi M; Lebesque J; Belderbos J; van den Heuvel M; Kwint M; Uyterlinde W; Vogel W; Sonke JJ
Radiother Oncol; 2013 Jan; 106(1):118-23. PubMed ID: 23219463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]